Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The Publications section description was reworded and the revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:30:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A notice about NIH government funding operating status has been removed from the page. The change does not affect core trial information such as eligibility, enrollment timelines, or outcomes.
    Difference
    0.2%
    Check dated 2025-11-18T06:50:41.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    No significant changes detected on the page; the content and structure appear the same.
    Difference
    0.2%
    Check dated 2025-11-03T20:42:26.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Updated location region name to Auvergne-Rhône-Alpes and added a government funding status notice; removed the old Rhone-Alpes designation and previous version. Overall, the page now reflects the updated region and current operating status information.
    Difference
    3%
    Check dated 2025-10-06T04:51:11.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-29T02:54:36.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Version bump from v3.0.1 to v3.0.2; removal of the Back to Top link. Overall, a minor update with no changes to pricing, stock availability, or core content.
    Difference
    0.1%
    Check dated 2025-09-14T18:50:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.